BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 12, 2003
View Archived Issues
Beneficial effects described for NN-2211 in the treatment of type 2 diabetes
Read More
Novel 5-HT1 receptor ligands discovered by GSK researchers
Read More
AstraZeneca presents dual CCR3 modulators/histamine H1 antagonists
Read More
New 5-HT6 receptor ligands designed by Akzo Nobel scientists
Read More
Two series of carbamate-based analgesic agents newly developed at Gruenenthal
Read More
AxyS presents novel factor VIIa/factor Xa inhibitors
Read More
Novel Jak kinase inhibitors for use in inflammation and cancer
Read More
ArQule completes Cyclis acquisition
Read More
Requip sNDA for restless legs syndrome filed
Read More
Aventis and Regeneron enter global agreement for VEGF Trap
Read More
Takeda acquires Japanese rights to antiobesity drug candidate ATL-962
Read More
Private equity financing to advance development of Panvac-VF and Prostvac-VF
Read More
NIAID grant supports development of oral smallpox drug at Chimerix
Read More
Phase I trial evaluates Psoraxine for psoriasis
Read More
Antisoma acquires Cytogen's R-1549 royalty rights
Read More
Clofarabine granted fast track status for pediatric leukemia
Read More
Improved glycemic control associated with exenatide in diabetes
Read More
SBIR grant supports BioSante's oral insulin development efforts
Read More
Rexin-G designated an orphan drug for pancreatic cancer
Read More
Phase I/II trial approved to evaluate Collidem in colorectal cancer
Read More
StaphVAX immunogenicity trial successfully completed
Read More
Positive endoscopy results for NCX-4016
Read More
NDA filed for cinacalcet hydrochloride
Read More
EntreMed grants Oxford BioMedica gene rights for ophthalmic applications
Read More
Abilify sNDA approved for maintaining stability in patients with schizophrenia
Read More
Taisho discusses design and SAR of group II mGluR antagonists at ACS meeting
Read More
Inhibitors of procollagen C-endopeptidase synthesized and evaluated as potential antifibrotic agents
Read More